Related Experiment Video

Updated: Nov 9, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.6K

Strategies to improve neurodevelopmental outcomes in babies at risk of neonatal hypoglycaemia

Jane M Alsweiler1, Deborah L Harris2, Jane E Harding3

  • 1Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand.

The Lancet. Child & Adolescent Health
|April 9, 2021
PubMed

Insights

Neonatal hypoglycemia, common in at-risk infants, may impact development. This review examines evidence on screening, prevention, and treatment to improve long-term neurodevelopmental outcomes.

Area of Science:

  • Neonatal medicine
  • Developmental pediatrics
  • Endocrinology

Background:

  • Neonatal hypoglycemia is linked to adverse childhood development, including visual-motor and executive function deficits.
  • It frequently affects asymptomatic, at-risk infants (preterm, SGA, LGA, maternal diabetes).
  • Current recommendations include early screening via frequent blood glucose monitoring.

Purpose of the Study:

  • To review the latest evidence on screening, prophylaxis, and treatment of neonatal hypoglycemia.
  • To assess the impact of these interventions on long-term neurodevelopmental outcomes in at-risk infants.

Main Methods:

  • This study is a narrative review of existing literature.
  • It focuses on evidence related to interventions for neonatal hypoglycemia and their long-term effects.

Main Results:

  • The review synthesizes current data on the efficacy of screening, buccal dextrose gel, infant formula, and intravenous dextrose for neonatal hypoglycemia.
  • Uncertainty remains regarding the long-term neurodevelopmental benefits of these interventions.

Conclusions:

  • Further research is needed to clarify the long-term neurodevelopmental benefits of screening, prophylaxis, and treatment for neonatal hypoglycemia in at-risk infants.

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.9K
Author Spotlight: Assessing the Feasibility of Using Amplitude-Integrated EEG During Neonatal Transport05:15

Author Spotlight: Assessing the Feasibility of Using Amplitude-Integrated EEG During Neonatal Transport

Published on: June 21, 2024

972

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
511
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.3K